These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 798529)

  • 21. Interactions between ethanol and amphetamine in mice and rats.
    Spreux-Varoquaux O; Simon P
    Prog Neuropsychopharmacol; 1980; 4(1):13-8. PubMed ID: 7190719
    [No Abstract]   [Full Text] [Related]  

  • 22. Catecholamines and drug-behavior interactions.
    Seiden LS; MacPhail RC; Oglesby MW
    Fed Proc; 1975 Aug; 34(9):1823-31. PubMed ID: 1097267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p-Chloramphetamine--species differences in the rate of disappearance and the lowering of cerebral serotonin.
    Miller KW; Sanders-Bush E; Dingell JV
    Biochem Pharmacol; 1971 Feb; 20(2):500-3. PubMed ID: 5150149
    [No Abstract]   [Full Text] [Related]  

  • 24. [Attempted neurochemical interpretation of natural behavior and behavior modified by neuroleptics].
    Procopiu-Constantinescu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(2):81-8. PubMed ID: 1081266
    [No Abstract]   [Full Text] [Related]  

  • 25. Central action of nomifensine.
    Maj J; Kapturkiewicz Z; Michaluk J
    Pol J Pharmacol Pharm; 1976; 28(6):557-62. PubMed ID: 189291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 27. Behavioural responses to drugs releasing 5-hydroxytryptamine and catecholamines: effects of treatments altering precursor concentrations in brain.
    Fernando JC; Curzon G
    Neuropharmacology; 1981 Feb; 20(2):115-22. PubMed ID: 7207710
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological and biochemical studies on binodaline.
    Maj J; Vetulani J; Michaluk J; Rogóz Z; Skuza G
    Arzneimittelforschung; 1983; 33(6):841-6. PubMed ID: 6604532
    [No Abstract]   [Full Text] [Related]  

  • 29. Behavioral effects of separate and combined administration of naloxone and d-amphetamine.
    Holtzman SG
    J Pharmacol Exp Ther; 1974 Apr; 189(1):51-60. PubMed ID: 4823299
    [No Abstract]   [Full Text] [Related]  

  • 30. Behavior and neurochemical changes following administration of 6-hydroxydopamine into the ventral tegmental area of the midbrain.
    Nakamura K; Nakamura K
    Jpn J Pharmacol; 1976 Apr; 26(2):269-73. PubMed ID: 945851
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperactivity in developing rats: sex differences in 6-hydroxydopamine and amphetamine effects.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1981 Jan; 14(1):5-10. PubMed ID: 7193330
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of certain tranquilisers, chlorpromazine metabolites and diethyldithiocarbamate on tissue amphetamine levels in the rat.
    Lal S; Sourkes TL; Missala K
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):122-30. PubMed ID: 4151045
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of neuroleptics on brain amphetamine concentrations in the rat.
    Lal S; Missala K; Sourkes T
    J Pharm Pharmacol; 1971 Dec; 23(12):967-9. PubMed ID: 4402025
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of catecholamines in the development of tolerance to barbiturates and ethanol.
    Tabakoff B; Ritzmann RF; Hoffman PL
    Adv Exp Med Biol; 1977; 85B():155-68. PubMed ID: 596278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The roles of monoamine neural systems in the anorexia induced by(+)-amphetamine and related compounds.
    Hollister AS; Ervin GN; Cooper BR; Breese GR
    Neuropharmacology; 1975 Oct; 14(10):715-23. PubMed ID: 1196470
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological properties of centrally-administered agents which interfere with neurotransmitter function: a comparison with the central depressant effects of ouabain.
    Doggett NS; Spencer PS
    Br J Pharmacol; 1973 Jan; 47(1):26-38. PubMed ID: 4352086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The basic pharmacology of oxypertine.
    Penn RG
    Postgrad Med J; 1972 Sep; 48(4):Suppl 4:7-11. PubMed ID: 4202024
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative studies on some effects of amphetamine in rats of different ages].
    Ziem M; Coper H; Broermann I; Strauss S
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(3):208-23. PubMed ID: 4248861
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Interaction of neuroleptic and cholinergic drugs with central dopaminergic mechanisms.
    Kelly P; Miller RJ; Sahakian B
    Br J Pharmacol; 1974 Nov; 52(3):430P-431P. PubMed ID: 4477511
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain.
    Schayer RW; Reilly MA
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):123-9. PubMed ID: 4725329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.